Rocket Pharma Seeks Gene Therapy Revolution For Genetic Heart Disease
Rocket Pharma has a pipeline of six gene therapy programs addressing cardiovascular and hematology-based diseases at the genetic level.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Yola Robert, Senior Contributor Tags: ForbesWomen /forbeswomen Leadership /leadership Innovation /innovation Healthcare /healthcare standard Source Type: news
More News: Cardiology | Cardiovascular | Gene Therapy | Genetics | Heart | Heart Disease | Hematology | Pharmaceuticals